\
&
Contact us
\
&
Contact us
This was 3 years ago
LocationOnline
ProgrammesDuring this virtual matchmaking event organized by Net4Society, the NCP network for Cluster 2, participants will have the opportunity to pre-arrange online meetings with other participants in order to identify possible project partners and to facilitate the setup of a Horizon Europe project consortium in Cluster 2.
A pre-proposal check event will follow on the following day of the brokerage event. At this event applicants will have the opportunity to discuss their proposals with experienced evaluators and National Contact Points to gain valuable feedback on their proposals.
More information on the Cluster 2 – brokerage event and pre-proposal check event 2023 can be found here.
Prior to this event an info day organized by the European Commission on the 2023 call topics of Cluster 2 will take place on 17 January 2023. More information here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
